Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
Progressive multifocal leukoencephalopathy (PML) is a rare but often fatal brain disease
caused by reactivation of the polyomavirus JC. Knowledge of the characteristics of PML has …
caused by reactivation of the polyomavirus JC. Knowledge of the characteristics of PML has …
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
Progressive multifocal leukoencephalopathy (PML) is a debilitating and frequently fatal
central nervous system (CNS) demyelinating disease caused by JC virus (JCV), for which …
central nervous system (CNS) demyelinating disease caused by JC virus (JCV), for which …
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
DB Clifford, A DeLuca, DM Simpson, G Arendt… - The Lancet …, 2010 - thelancet.com
Background Treatment of multiple sclerosis with natalizumab is complicated by rare
occurrence of progressive multifocal leukoencephalopathy (PML). Between July, 2006, and …
occurrence of progressive multifocal leukoencephalopathy (PML). Between July, 2006, and …
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
X Boumaza, B Bonneau, D Roos‐Weil… - Annals of …, 2023 - Wiley Online Library
Objective Our aim was to assess the real‐world effectiveness of immune checkpoint
inhibitors for treatment of patients with progressive multifocal leukoencephalopathy (PML) …
inhibitors for treatment of patients with progressive multifocal leukoencephalopathy (PML) …
Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis
Objective To describe the development of progressive multifocal leukoencephalopathy
(PML) in patients with rheumatoid arthritis (RA) treated with rituximab. Design Case study …
(PML) in patients with rheumatoid arthritis (RA) treated with rituximab. Design Case study …
HIV-associated opportunistic infections of the CNS
Survival in people infected with HIV has improved because of an increasingly powerful array
of antiretroviral treatments, but neurological symptoms due to comorbid conditions, including …
of antiretroviral treatments, but neurological symptoms due to comorbid conditions, including …
Progressive multifocal leukoencephalopathy and other forms of JC virus disease
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain
caused by the JC virus (JCV). PML usually occurs via reactivation of JCV when an immune …
caused by the JC virus (JCV). PML usually occurs via reactivation of JCV when an immune …
The human JC polyomavirus (JCPyV): virological background and clinical implications
HH Hirsch, P Kardas, D Kranz, C Leboeuf - Apmis, 2013 - Wiley Online Library
JC polyomavirus (JCPyV) was the first of now 12 PyVs detected in humans, when in 1964,
PyV particles were revealed by electron microscopy in progressive multifocal …
PyV particles were revealed by electron microscopy in progressive multifocal …
Progressive multifocal leukoencephalopathy in transplant recipients
Objective: Transplant recipients are at risk of develo** progressive multifocal
leukoencephalopathy (PML), a rare demyelinating disorder caused by oligodendrocyte …
leukoencephalopathy (PML), a rare demyelinating disorder caused by oligodendrocyte …
Dimethyl fumarate-associated lymphopenia: risk factors and clinical significance
EE Longbrake, RT Naismith, BJ Parks… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Background Dimethyl fumarate (DMF), a disease-modifying therapy for multiple sclerosis
(MS), causes lymphopenia in a fraction of patients. The clinical significance of this is …
(MS), causes lymphopenia in a fraction of patients. The clinical significance of this is …